Clinical Trial Update: OP2C : Prialt® Observatory in Clinical Practice

View source ↗

Summary

OP2C: Prialt Observatory in Clinical Practice is currently recruiting to observe the use of Prialt (ziconotide) in patients with refractory chronic pain at the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Prialt (ziconotide)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Refractory Pain | Status: RECRUITING